logo

Bausch Health Companies Inc. (BHC.TO)



Trade BHC.TO now with
  Date
  Headline
8/6/2020 7:01:38 AM Bausch Health Companies Q2 Revenues $1.664 Bln; GAAP Net Loss $326 Mln
8/6/2020 7:00:33 AM Bausch Health Companies Intends To Spin Off Its Eye Health Business Into An Independent Publicly Traded Entity
6/23/2020 7:05:38 AM Bausch Health Companies And Ortho Dermatologics Announce ARAZLO Lotion, 0.045%, Is Available Commercially
6/4/2020 7:09:35 AM FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE Daily Disposable Silicone Hydrogel Contact Lenses
5/27/2020 7:25:36 AM Bausch + Lomb Reports European Launch Of LuxSmart And LuxGood Preloaded Intraocular Lenses
5/27/2020 7:03:26 AM Bausch + Lomb Announces European Launch Of LuxSmart And LuxGood Preloaded Intraocular Lenses
5/11/2020 7:11:02 AM Bausch Health Launches $1.25 Bln Private Offering Of Senior Notes Due 2029
5/7/2020 7:18:04 AM Bausch Health Companies Q1 Net Loss $152 Mln Vs. Net Loss $52 Mln Last Year
4/29/2020 7:10:55 AM Bausch Health Companies Says FDA OKs JUBLIA Topical Solution, 10%, In Patients As Young As Six Years Old
4/13/2020 7:06:58 AM Bausch Health Initiates VIRAZOLE Clinical Study In Patients With COVID-19
3/31/2020 7:07:57 AM Bausch Health Announces Favorable Topline Results FromPhase 2 Study Of Rifaximin SSD IR
3/13/2020 7:03:53 AM Bausch Health To Reduce Debt By About $100 Mln Using Cash Generated From Operations
1/28/2020 7:20:14 AM Bausch Health And Clearside Biomedical Announce Publication Of PIVOTAL Phase 3 Data ON XIPERETM In Ophthalmology
1/13/2020 6:50:22 AM Ortho Dermatologics Publishes Pivotal Phase 3 Data On ARAZLO Lotion, 0.045% In The Journal Of Drugs In Dermatology
1/6/2020 8:30:30 AM Bausch + Lomb Unveils Expanded Parameters For Biotrue ONEday For Astigmatism Daily Disposable Contact Lenses
12/20/2019 8:31:33 AM Bausch Health Licenses Novaliq' NOV03 Treatment For Dry Eye Disease Associated With Meibomian Gland Dysfunc